Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 679.70M P/E - EPS this Y -15.10% Ern Qtrly Grth -
Income -139.65M Forward P/E -5.08 EPS next Y 11.10% 50D Avg Chg -31.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 6.00%
Dividend N/A Price/Book 3.05 EPS next 5Y - 52W High Chg -56.00%
Recommedations 2.00 Quick Ratio 4.50 Shares Outstanding 36.21M 52W Low Chg 218.00%
Insider Own 25.01% ROA -48.20% Shares Float 22.44M Beta -0.49
Inst Own 64.99% ROE -85.09% Shares Shorted/Prior 7.59M/7.14M Price 19.20
Gross Margin - Profit Margin - Avg. Volume 853,767 Target Price 32.63
Oper. Margin - Earnings Date Jul 31 Volume 641,861 Change -7.51%
About Biomea Fusion, Inc.

Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Biomea Fusion, Inc. News
12/02/24 Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
11/18/24 Late-Breaker Oral Presentation Showing New Analysis from the Escalation Portion of COVALENT-111 Presented at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)
11/13/24 We're A Little Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate
10/30/24 Biomea Fusion Presents Preclinical Data Showing Icovamenib (BMF-219) Enhanced Effectiveness of GLP-1-Based Therapies and Introduces BMF-650, a Next-Generation, Oral Small-Molecule GLP-1 Receptor Agonist Candidate
10/29/24 Biomea Fusion Reports Third Quarter 2024 Financial Results and Corporate Highlights
10/21/24 Biomea Fusion Announces Approval of “icovamenib” as International Nonproprietary Name for BMF-219
10/15/24 Biomea Fusion to Host Conference Call and Webcast on Wednesday, October 30th at 4:30 pm ET to Announce Our Lead Clinical Candidate, BMF-650, a Next-Generation, Oral Small-Molecule GLP-1 Receptor Agonist and Preclinical Data Combining BMF-219 with a GLP-1 RA-Based Therapy
10/10/24 Morning Movers: Arcadium Lithium surges after deal to be acquired
10/07/24 Biomea Fusion to Present at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)
06:34 AM Independent Director of Biomea Fusion Michael J. Hitchcock Buys 200% More Shares
10/01/24 Biomea Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes Experts
09/27/24 FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate
09/27/24 Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials
09/27/24 BMEA Stock Up 9% as FDA Lifts Clinical Hold on 2 Diabetes Studies
09/26/24 FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials
08/17/24 With 51% institutional ownership, Biomea Fusion, Inc. (NASDAQ:BMEA) is a favorite amongst the big guns
08/14/24 Wall Street Analysts Think Biomea Fusion (BMEA) Could Surge 317.86%: Read This Before Placing a Bet
07/31/24 Biomea Fusion Reports Second Quarter 2024 Financial Results and Corporate Highlights
06/29/24 Biomea Fusion, Inc. (BMEA): Why Did Analysts Give This Biotech Penny Stock a Moderate Buy Rating?
06/28/24 Why Are Hedge Funds Shorting Biomea Fusion, Inc. (BMEA)?
BMEA Chatroom

User Image clarksonhockey Posted - 43 minutes ago

$BMEA Accumulate over time . stash it away and someday boom. Like MRTX and KRYS.

User Image clarksonhockey Posted - 43 minutes ago

$BMEA looking for a big update this month and stock hiting 12-15. Wont Sell. This is one you hold and retire.

User Image Moo53isLoo53 Posted - 14 hours ago

$BMEA Piper Sandler fireside chat scheduled for 10:00 am EST tomorrow 12/3 and Evercore fireside chat scheduled for 7:55 am EST on Thursday 12/5. Data coming any day now, my body is ready.

User Image induscapital Posted - 15 hours ago

$BMEA REDWOOD CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and development of oral covalent small molecules to treat and improve the lives of patients with diabetes, obesity, and genetically defined cancers, today announced that on December 2, 2024, the compensation committee of Biomea’s board of directors granted one new employee non-qualified stock options to purchase an aggregate of 30,000 shares of the Company’s common stock. The shares underlying the employee’s stock options will vest 1/16 on a quarterly basis over four years, subject to the employee’s continued employment with the Company on such vesting dates. The above-described award was made under Biomea’s 2023 Inducement Equity Plan (the “Plan”).

User Image Moo53isLoo53 Posted - 16 hours ago

$BMEA feeling a lil spicy, might switch all my shares into January calls cause I know this is going to jump hard. Institutional ownership increasing, options sentiment consistently bullish, primed for a squeeze with such high SI, and heavily oversold? Boy, ONE day of high volume will have this through the roof.

User Image hashbridges Posted - 1 day ago

$BMEA honestly the price action here has been total BS for the past month. It’s trading at like 3X cash if that. Little downside and ridiculous upside. But I expect it will start running up in anticipation of Dec data as otherwise it could just explode above $20 once that drops.

User Image ClarissaRuiz Posted - 1 day ago

$BMEA $RZLT $STRO 🔥 MYNZ I'm buying! 🚀 A 40:1 RS is set for Dec 3, with big news likely to follow. Think about it something big seems to be in motion. Let’s break it down: a $30M offering, then a Thermo Fisher (TMO) partnership, Thermo backed by BlackRock and Vanguard. Think they’ll step aside? Post-RS, 80M shares shrink to a 2M tiny float. Expect news on the offering and more, possibly reshaping Mainz's path. This could hit $50/share. FOMO is real I'm adding now!

User Image clarksonhockey Posted - 1 day ago

$BMEA Looking for a big move this week. Maybe HUGE HUGE HUGE.

User Image induscapital Posted - 11/30/24

$BMEA $VKTX $SMMT $MDGL Is BMEA going to make big move on data release in December, https://www.marketbeat.com/stocks/NASDAQ/BMEA/forecast/#google_vignette Analyst ratings are positive with all buys and multiple of current SP as target price At the same time it is one of top shorted stock Whom to trust or just go with volatility ahead

User Image twoburger Posted - 11/29/24

$BMEA $50

User Image Jimmybelanger3 Posted - 11/28/24

$BMEA $20 stock

User Image Pukkaa56 Posted - 11/27/24

$BMEA Added 1000

User Image Biomea Posted - 11/27/24

Just someone who is really bullish on $BMEA. I'm definitely not a bot. I recommend watching the video I posted on YouTube. They just recently formed a global scientific advisory board with 22 world renowned experts and they just attended the Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD). I have a good feeling the data is going to be good in December.

User Image RoyMunson69 Posted - 11/27/24

$BMEA Ok yeah scam

User Image CBARRR8 Posted - 11/26/24

$BMEA The data recently presented was good but not spectacular. However, that was only 4 week treatment and how the effects were sustained after 26 weeks. The new data for December will be 8 and 12 week treatment and in vitro data indicates that the treatment effects are cumulative. If this pans out, this new first in class will be first line tretment for all diabetics.

User Image clarksonhockey Posted - 11/26/24

$BMEA train leaving the station again. Do clue why this sold off this month. But the move is back. And shorts are gonna get smoked.

User Image clarksonhockey Posted - 11/26/24

$BMEA Added again. I agree. This is a powder keg. Didn't sell ay 12. Wont sell at 20. This is a game changer and the Wall St analysts love it.

User Image TendyDawg Posted - 11/25/24

$BMEA that's wtf I'm talkin bout let's rally into the data then 🌙

User Image Biomea Posted - 11/25/24

$BMEA I recommend everyone watch this video that Biomea released on their YouTube channel 3 days ago. https://youtu.be/5Dk15VqlL5Q?si=67vJL4Dd_4tMx3gc

User Image Pukkaa56 Posted - 11/23/24

$BMEA when information ?

User Image lucky9150 Posted - 11/22/24

$BMEA or 80% haircut with fail data. Let's pray 🙏 for the best.

User Image lucky9150 Posted - 11/22/24

$BMEA , with good data, we will see 400% 500% gain in a day. 9 millions shorts. LFG

User Image lucky9150 Posted - 11/21/24

$BMEA , does anyone have an idea of price action if data is good or bad ?

User Image twoburger Posted - 11/21/24

$BMEA go $50

User Image ClarkeDevlin Posted - 11/21/24

$BMEA Anyone think this is completely a fools errand now that RFk is now head of health and wants to get rid of government plans to cure obesity with drugs like ozempic? Any thoughts on how that might have affected the drop? Also, I'm kind of new to all of this but even after Oct 30 you have D. Borel Capital and Piper Sandler still saying this is overweight and is going to sky rocket and out preform. Found this by chance on the scanner at the start of Oct when you could see by then they weren't going to have much cash reserves. Why then were so many analysts promising the moon when the info was there only for this to possibly shit the bed if the future clinical data results might possibly be mediocre...?

User Image amda Posted - 11/19/24

$BMEA stopped out with a small gain

User Image amda Posted - 11/19/24

$BMEA added 6.23

User Image amda Posted - 11/19/24

$BMEA looks like I spoke too soon...

User Image amda Posted - 11/19/24

$BMEA market is sloppy, but $BMEA looks good early...

User Image Klinson8 Posted - 11/19/24

$BMEA is there any scheduled updates for this? Thank you in advance for any information

Analyst Ratings
Scotiabank Sector Outperform Sep 27, 24
HC Wainwright & Co. Buy Sep 27, 24
Barclays Equal-Weight Sep 27, 24
Truist Securities Buy Sep 27, 24
Rodman & Renshaw Buy Sep 26, 24
Capital One Overweight Aug 29, 24
Citigroup Buy Aug 27, 24
HC Wainwright & Co. Buy Aug 1, 24
HC Wainwright & Co. Buy Jun 25, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
A2A Pharmaceuticals, Inc. 10% Owner 10% Owner May 12 Sell 33.84 25,000 846,000 3,625,000 05/17/23
A2A Pharmaceuticals, Inc. 10% Owner 10% Owner May 08 Sell 34.25 250,000 8,562,500 3,650,000 05/10/23
A2A Pharmaceuticals, Inc. 10% Owner 10% Owner Apr 20 Sell 29.1188 200,000 5,823,760 3,900,000 04/26/23
A2A Pharmaceuticals, Inc. 10% Owner 10% Owner Mar 31 Sell 31.25 200,000 6,250,000 4,100,000 04/06/23
A2A Pharmaceuticals, Inc. 10% Owner 10% Owner Aug 16 Buy 13.872 30,684 425,648 4,300,000 08/19/22
A2A Pharmaceuticals, Inc. 10% Owner 10% Owner Jul 21 Sell 11.21 34,658 388,516 4,330,684 07/25/22
A2A Pharmaceuticals, Inc. 10% Owner 10% Owner Jun 24 Sell 11.76 34,658 407,578 4,365,342 06/28/22
Valle Franco Chief Financial Offi.. Chief Financial Officer Jan 14 Buy 8.6767 10,000 86,767 10,000 01/18/22